To celebrate AMP's 25th anniversary, we've compiled a timeline of notable events and initiatives that made us the vibrant society we are today. Thank you to our members and dedicated volunteers for your service to our society and field.
At the 3rd UAREP-sponsored Molecular Diagnostics Workshop held in Bethesda, Maryland in November 1994, AMP was founded. An Action Committee was set up to formally establish the Association and create a framework for the future growth and development of AMP. The members of the Action Committee were: David Cooper (Chair), Carleton Garrett (Vice-Chair), Jeffrey Cossman, Tom Frank, Jeffrey Kant, Anthony Killeen, Mark Lovell, Ronald McGlennen, Mark Sobel, Steven Thibodeau, Cheryl Willman with Frances Pitlick as the liaison with UAREP. “At that time, none of the large pathology societies had much interest in promoting molecular pathology, so we decided that a free-standing society was preferable to affiliation with an established group. Although we were all Americans, we chose the name Association for Molecular Pathology so that it specifically did not contain the words "national" or "American" and would thus represent an international effort, and an organization without borders. Mark Sobel, Jeff Kant, Cheryl Willman, Jeff Cooper, Ron McGlennen, and colleagues mapped out the organizational chart for the society and asked people to sign up for any of several committees that would develop bylaws and establish structure for the society. I remember signing up for several of these committees. To facilitate sign-up, huge pieces of white paper were ripped from one of those easel-based flip charts, and the about 8 of these huge white papers were taped to the wall of the hotel corridor outside the meeting room. At top of each paper was a committee name, such as "Bylaws Committee." Many of us scrawled our names to these papers and we were thus immediately put to work and then later recruited to run for office once the bylaws and mechanisms for voting were established. Thus was born the Association for Molecular Pathology.” (Peggy Gulley, Personal Communication, 2002)
Chair of Action Committee: David L. Cooper, MD
Annual Meeting: Hyatt Regency Minneapolis, MN, November 10 - 12, 1995
• Society Bylaws adopted November 12, 1995.
• "Youthquake" for those who were there.
• Social event at Speakeasy Cave in St. Paul where "Guido" (aka David Cooper) was the star.
• The association's Listserv bit.listserv.mxdiag-l facilitated internet communication prior to CHAMP.
• Ron McGlennen, Editor of the first AMP Newsletter.
• Fran Pitlick, Executive Officer of UAREP and ASIP, AMP’s first Executive Officer.
President: Jeffrey A. Kant, MD, PhD
Annual Meeting: Omni Inner Harbor Hotel, Baltimore, MD, November 14 - 17, 1996
• "Even with the best planning there always seems to be the odd thing that's overlooked. This year it was thumb-tacks for the posters! Thanks to Tim O'Leary for accompanying me to the local Kinko's to purchase 600 of these at 9PM the night before the conference began!" (Tony Killeen, AMP Newsletter Jan 1997).
• The Saturday evening dinner was at the B&O Railroad Museum, organized by Jeff Kant and Fran Pitlick.
• Bomb scare at Baltimore Washington International Airport.
• CHAMP (CHat AMP) was launched in May 1996 and administered by Jeff Kant.
• Year of the first Test Directory and Membership Directory.
• Ad hoc committee (Chair, Peggy Gulley) established to evaluate possible journal affiliation.
• Dan Farkas succeeded Ron McGlennen as Editor of AMP Newsletter.
President: Margaret Gulley, MD
Annual Meeting: Wyndham Emerald Plaza Hotel, San Diego, California, November 13-15, 1997
• First special session for medical technologists.
• First corporate workshops.
• Meeting program expanded to 2 workshops per subdivision.
• First Welcome Reception.
• The first AMP logo was adopted.
• AMP went electronic - home page, http://www.pds.med.umich.edu/users/amp managed by Tony Killeen.
• Jeff Kant spearheaded corporate sponsorship of the AMP Award for Excellence in Molecular Diagnostics.
President: Cheryl Willman, MD
Annual Meeting: Hyatt Regency Crystal City, Crystal City, VA, November 5 – 8, 1998
• First recipient of Award for Excellence in Molecular Diagnostics (sponsored by Visible Genetics, Inc.): Francis Collins, MD, PhD.
• First session on “Technical Topics".
• Additional Plenary Session featured the best abstracts.
• Major goal of AMP accomplished: new specialty of Molecular Genetic Pathology created and approved by American Board of Medical Specialties.
• AMP Test Directory updated.
• AMP signed Memo of Understanding with the American Society for Investigative Pathology to create The Journal of Molecular Diagnostics (JMD) as part B of The American Journal of Pathology; the Joint Journal Oversight Committee was formed.
President: Mark Sobel, MD, PhD
Annual Meeting: Adams Mark Hotel, St. Louis, MO, November 4-7, 1999
• Abstracts from meeting published in the first issue of The Journal of Molecular Diagnostics (JMD).
• First issue of AMP's official journal, The Journal of Molecular Diagnostics, American Journal of Pathology Part B.
• Appointment of Karen Kaul as Senior Editor of JMD.
• Official financial separation from UAREP (Articles of Incorporation of AMP filed in Maryland).
• Launch of AMP website, www.ampweb.org, including Membership Directory accessible by members of AMP only.
• AMP’s first published paper, “Association for Molecular Pathology Statement: Recommendations for inHouse Development and Operation of Molecular Diagnostic Tests” American Journal of Clinical Pathology 1999;111:449-463.
• AMP co-sponsored overseas molecular diagnostics meeting in Zwolle, The Netherlands.
President: Debra Leonard, MD
Annual Meeting: Denver Hyatt Regency Hotel, Denver, CO, November 9-12, 2000
• Dan Farkas spearheaded corporate sponsorship for trainee awards (Young Investigator Awards).
• First Young Investigator Awards.
• JMD now online.
• AMP plays a role in new efforts to bring oversight to genetic testing through Secretary Advisory Committee on Genetic Testing (SACGT), CDC Forum and the FDA.
• Jeff Kant organized AMP’s application for a Companion Meeting at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting.
President: Karl Voelkerding, MD
Annual Meeting: Loews Philadelphia Hotel, Philadelphia, PA, November 15 - 18, 2001
• Discussion Group on Connexin 26 testing meets.
• Two ad hoc committees established: AMP Policy Committee (Andrea Ferreira-Gonzalez, PhD as first Chair).
• Inaugural AMP Companion Meeting at USCAP, organized by Marc Ladanyi, Standing Room Only!
• JMD fully indexed in MEDLINE and Index Medicus.
• JMD no longer listed as Part B of AJP.
• Mark Sobel succeeded Fran Pitlick as AMP’s Executive Officer.
• CHAMP server moved from Pittsburgh to yahoogroups.
• Terry Dunn succeeded Jeff Kant as CHAMP Moderator.
• AMP and ASIP signed a new Memo of Understanding, effective January 2002, to continue publishing JMD.
• Karen Kaul “promoted” to Editor-in-Chief of JMD, effective January 2002.
President: Karen Kaul, MD
Annual Meeting: Adams Mark Hotel, Dallas, TX, November 14 - 17, 2002
• First AMP Technologists Awards (sponsored by Third Wave Technologies, Inc).
• First College of American Pathologists Inspector Training Session.
• First workshop on ACGME Accreditation for Molecular Genetics Pathology: A Workshop and Discussion for Fellowship Program Directors.
• Establishment of AMP Web Library (Editor: Jan Nowak).
• First audio conference (Topic: Cystic Fibrosis), organized by Karl Voelkerding.
• Creation of position for Junior Member in Training and Education Committee.
• Establishment of Professional Relations Committee as a standing committee (formerly the ad hoc AMP Policy Committee).
President: Daniel H. Farkas, PhD, HCLD
Annual Meeting: Wyndham Palace Resort & Spa Orlando, FL, November 19 - 23, 2003
• HSV and CMV working groups formed.
• Ad Hoc Strategic Planning Committee established (Chair, Jeff Kant) and presented recommendations to AMP Council.
• Debra Leonard appointed to Secretary’s Advisory Committee on Genetics, Health and Society.
• Test Directory online: Infectious Diseases, Solid Tumors and Hematopathology.
• CHAMP moved from yahoogroups to new listserv, CHAMP@lists.asip.org. No more commercial advertising!
• JMD ranked 5th out of 64 Pathology journals.
• Teresita Cuyegkeng Redondo and Marlene Sabbath-Solitare succeeded Dan Farkas as Editors of the AMP Newsletter; Newsletter acquired a new look.
President: Angela M. Caliendo, MD, PhD
Annual Meeting: Century Plaza Hotel and Spa, Los Angeles, CA, November 10 - 14, 2004
• AMP Celebrates 10th anniversary
• First time online Abstract Submission.
• AMP hires a new Director of Scientific Programs - Mary Williams.
• AMP office moved to expanded quarters.
• AMP gets a new logo.
• AMP acquired two new website domains, www.molecularpathology.org and www.amp.org.
• Election of officers now done online.
• Karen Kaul appointed to a second term as Editor-in-Chief of JMD, effective January 2005.
President: Mark A. Lovell, MD
Annual Meeting: Scottsdale, AZ
• Growing Pains: Attendees very much enjoyed the Westin Kierland but the meeting had outgrown the venue.
• First time abstracts are rejected.
• Jeff Kant receives first AMP Leadership Award.
• Advocacy regarding gene patents begins: input provided for NAS document on gene patents & amicus in LabCorp v Metabolites.
• 1st Tech Reps on Program Committee.
• CMS begins MUE (Medically Unbelievable Edits) initiative; AMP joins CAP, ACMG, et al, with strong response.
• Incoming volunteers begin attending committee meetings at annual meeting (orientation).
• JMD expands to 5 issues/year.
President: Barbara A. Zehnbauer, PhD
Annual Meeting: Orlando, FL
• Shuji Ogino gives his first nomenclature early bird.
• PGx on the program.
• 1st Community Pathology Outreach Course.
• JMD CME program begun.
• Strategic Planning Committee (SPC) – later renamed the Strategic Opportunities Committee (SOC) – made a Standing Committee, with the President-Elect as a voting member.
• Technologist Travel Award established.
• AMP joins amici in LabCorp v Metabolite case.
• AMP joins the AFIP Coalition and supports the preservation of the core functions of the Armed Forces Institute of Pathology (AFIP).
President: Andrea Ferreira-Gonzalez, PhD
Annual Meeting: The Hyatt Regency Century Plaza Hotel, Los Angeles, CA, November 7-10, 2007
• Attendance breaks 1,000.
• Council decides to standardize the annual meeting days, Thursday-Saturday, beginning with the 2010 meeting.
• Molecular Genetic Pathology Review Course begun, Kevin Halling 1st director.
• AMP writes letter of support for GINA to Sen. Ted Kennedy’s staffer, Jennifer Leib, who becomes AMP’s Government Relations Consultant in 2009.
• PRC begins advocacy regarding oversight of LDTs; Sens. Ted Kennedy and Barack Obama each introduce legislation.
• Streamlined Publications Policy adopted.
• Council establishes the Membership & Professional Development Committee (MPDC) as an ad hoc committee to address membership issues, volunteer management, and leadership development.
President: Gregory J. Tsongalis, PhD
Annual Meeting: The Gaylord Texan Resort & Convention Center, Grapevine, TX, October 29-November 2, 2008
• Social event reintroduced.
• Trick-or-Treat in the Exhibit Hall.
• JMD begins publishing 6 issues a year.
• Emeritus Membership category established.
• Hires first government relations consultants (Jennifer Leib and Robert Wells of HealthFutures); 501h election; begin lobbying.
• Online education initiated with webinars & case studies.
• Economic Affairs Committee begun as the CPT subcommittee of the PRC.
• CPT Coding initiative begun.
• Process for non-US affiliates established.
• Council notes there is no widely accepted definition of “clinical utility.” It was recommended that AMP design a process that includes a definition, e.g., “Does the evidence support the claims being made?”
• AMP issues new statement opposing gene patents and the exclusive licensing of genetic discoveries.
• Volunteer terms of service begin at conclusion of the annual meeting.
President: Jan A. Nowak, MD, PhD
Annual Meeting: The Gaylord Palms Resort & Convention Center, Kissimmee, FL, November 19-22, 2009
• AMP celebrates its 15th anniversary
• JMD celebrates its 10th anniversary
• SAMs credits initiated for MGP review course with online pre- & post- tests.
• AMP becomes the primary plaintiff in gene patent lawsuit “AMP et al v USPTO et al”
• Economic Affairs Committee made a Standing Committee
• AMP Council notes the loss of Sen. Edward Kennedy and his contributions to civil rights, health care (including GINA), and to pathology. He was the driving force behind legislation to preserve the core functions of the AFIP.
• Prioritized list of needed Standardized Reference Materials for molecular tests given to NIST.
• AMP publishes white paper that outlines new molecular pathology CPT codes as a potential solution to the lack of transparency associated with the current "stacking" codes. AMA later establishes new codes, which CMS implements in 2013.
President: Karen Mann, MD, PhD
Annual Meeting: San Jose McEnery Convention Center, San Jose, CA, November 17-20, 2010
• First meeting held in a convention center instead of a hotel.
• Council approves Elsevier managed publishing for JMD.
• AMP begins advocacy opposing FDA oversight of LDTs.
• Whole Genome Analysis Working Group formed.
• Process established to select USCAP moderators from pathologist members.
• New strategic planning process begun. Steering Committee Karen Mann, Jan Nowak, Tim O’Leary, Barbara Zehnbauer, Jennifer Hunt, and Iris Schrijver, plus the 2011 SPC Chair, Karen Kaul. Consultant is John Ball, recently retired ASCP EVP.
• Lung biomarkers guidelines begun with CAP & IASLC.
• Subdivision Chairs made voting members of Council.
• First International Membership Grants awarded.
President: Timothy O'Leary, MD, PhD
Annual Meeting: Gaylord Texan Hotel & Convention Center, Grapevine, TX, November 17-19, 2011
• First meeting to offer PACE credits.
• Specialty lunches initiated.
• Membership exceeds 2,000.
• First formal strategic plan approved. Areas: Advocacy, Education, Innovation & Improved Patient Care, Management, Governance.
• AMP joins amici in Prometheus v Mayo.
• AMP and other organizations working on new molecular pathology CPT codes form coalition to pursue legislation to deem PhDs as Qualified Healthcare Providers.
• Mary Williams named Executive Director; Mark Sobel named Executive Officer Emeritus.
• Council approves governances changes recommended in the strategic plan: “AMP governance shall be by a Board of Directors and its Executive Committee” and established a Finance Committee and renamed the Strategic Planning Committee the Strategic Opportunities Committee (primary charge to consider the external environment).
• CHAMP 2.0 on HigherLogic platform launched at year end.
• Rami Mahfouz organized AMP’s first co-sponsored non-U.S. conference: outreach course in conjunction with meeting of the Arab division of the IAP. AMP sent 3 speakers; 23 attendees joined AMP.
President: Iris Schrijver, MD
Annual Meeting: Long Beach Convention & Entertainment Center, Long Beach, CA, October 25 - 27, 2012
• Attendance grows to 1,500.
• Early bird sessions so full that some attendees watch through the door.
• Subdivision representatives to the Program Committee elected.
• AMP mourns the loss of Jeff Kant; Jeffrey A. Kant-AMP Education Fund established.
• Anticipating at least some molecular pathology CPT codes will be placed on the PFS, AMP-led multi-society coalition lobbies Congress to deem PhDs as Qualified Healthcare Providers.
• CMS places new molecular pathology CPT codes on the CLFS, eliminating PhD legislation argument; CMS designates gapfill method to price the new codes.
• ASIP notifies AMP that it will not renew the management agreement, which ends Dec 31, 2013. After considering researched options, the Board decides that AMP will manage its own office and will apply to join FASEB.
• Formal annual Board orientation & training begun.
President: Jennifer L. Hunt, MD, MEd
Annual Meeting: Phoenix Convention Center, Phoenix, AZ, November 14 -16, 2013
• Members interested in forming an Informatics Interest Group meet together after the Welcome Reception. This interest group grows rapidly and soon becomes the Informatics Subdivision.
• SCOTUS rules 9-0 in favor of the plaintiffs in the AMP v Myriad (gene patent) lawsuit. DNA sequences are no longer patent eligible!
• First major multi-society clinical practice guideline published, “Molecular Testing Guideline for the Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors,” by Neal Lindeman, et al. JMD, July 2013.
• AMP welcomes its first three affiliate organizations: The Hong Kong Society for Molecular Diagnostic Sciences, The Molecular Pathology Association of India and The Korean Society for Laboratory Medicine.
• Membership categories reorganized into World Bank income categories.
• Board celebrates 5-year strategic plan 73% implemented in 2-1/2 years; revises Mission Statement.
• AMP Leadership Award renamed Jeffrey A. Kant Leadership Award.
• AMP becomes a sponsor of the IOM Translating Genomic-Based Research for Health Genomics Roundtable (“IOM Genomics Roundtable”).
• New Logo adopted.
• AMP becomes a Cooperating Society of the American Board of Pathology.
• Newsletter renamed AMPlifications.
President: Elaine Lyon, PhD
Annual Meeting: Gaylord National Hotel & Convention Center, National Harbor, MD, November 12 -15, 2014
• AMP celebrates 20th anniversary.
• Advocacy day held on Capitol Hill with over 70 AMP members participating.
• AMP holds Capitol Hil briefing.
• Standing room only session with FDA on LDPs.
• PETA protestors during Dr. Francis Collins' presentation.
• AMP introduces and defines the term “Laboratory Developed Procedures” in “Revisiting Oversight and Regulation of Molecular-Based Laboratory-Developed Tests” by Andrea Ferreira-Gonzalez, et al. JMD, January 2014.
• Ad hoc Awards Committee begun; Debra Leonard, chair.
• Board revises Vision Statement.
• Leadership Fund renamed the Strategic Initiatives Fund.
• AMP begins self-management.
• New CHAMP platform (Socius) launched.
President: Janina A. Longtine, MD
Annual Meeting: Austin Convention Center, Austin, TX, November 5-7, 2015
• Flooding shuts down Austin airport.
• Congressman Michael Burgess, MD (R-TX) speaks at session on CLIA modernization.
• AMP Central - AMP's booth in the Exhibit Hall - makes it debut.
• Meeting attendance exceeds 2,000.
• AMP releases Molecular Diagnostic Perfect Storm white paper.
• The German Society of Pathology (DGP) becomes AMP's fourth affiliate organization.
• Planning begins for AMP's inaugural Global Congress.
• AMP releases microcosting models to help laboratories estimate the cost basis of their genomic sequencing procedure CPT codes.
• The International Affairs Committee is established with Lei Po (Chris) Wong as Chair. The IAC began in 2010 as a working group of the Membership Affairs Committee
• T&E Committee releases popular NGS 101 webinar series.
• Several AMP members are seated on the CMS Advisory Panel established by PAMA, Vicky Pratt as AMP’s representative.
• AMP releases CLIA Modernization Proposal
• AMP leads advocacy on opposing FDA draft guidance on oversight of laboratory developed testing procedures
President: Charles E. Hill, MD, PhD
Annual Meeting: Charlotte Convention Center, Charlotte, NC, November 10-12, 2016
• First Medscape broadcast from AMP annual meeting.
• Pre-meeting celebration at NASCAR Museum with race car simulators.
• AMP hosts patient and patient advocacy groups at first Lunch and Learn Event.
• AMP members participate in a legislative hearing on laboratory developed testing procedures.
• Advocacy newsletter, The ChAMPion, is launched.
• Economic Affairs Committee holds its first Genomic Medicine Payer Summit in Chicago.
• AMP submits eight new CPT code change proposals.
• AMP co-hosts hill briefing with ACMG and IDSA on oversight of laboratory developed testing procedures.
President: Federico A. Monzon, MD
Annual Meeting: Calvin L. Rampton Salt Palace, Salt Lake City, UT, November 14-16, 2017
• AMP introduces Innovation Spotlight Stages in the Exhibit Hall.
• Inaugural Global Congress on Molecular Pathology held April 3-5 in Berlin, Germany.
• AMP welcomes two affiliate organizations: the Brazilian Society of Clinical Pathology and Laboratory Medicine (SBPC) and The Italian Society of Pathology and Translational Medicine (SIPMET).
• AMP Clinical Practice Committee and its working groups continue their production of influential clinical practice guidelines, with the publication of “Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer,” by Marilyn Li, et al. JMD, January 2017 and “Molecular Biomarkers for the Evaluation of Colorectal Cancer,” by Antonia Sepulveda, et al. JMD, March 2017.
• T&E Committee launches popular “Molecular in my Pocket” reference cards.
• T&E Committee matures online education, with AMPEDTM Online, www.educate.amp.org.
• AMP launches new website.
President: Kojo S. J. Elenitoba-Johnson, MD
Annual Meeting: Henry B. Gonzalez Convention Center, San Antonio, TX, November 1-3, 2018
• Halloween costumes on Corporate Workshop Day.
• Live demonstration of an ultrasound using a mobile device during Jonathan Rothberg's keynote session.
• Inaugural AMP Europe Congress held April 30 - May 2, in Rotterdam, The Netherlands.
• AMP welcomes seventh affiliate, the American University of Beirut Medical Center.
• AMP is awarded its first grant funding for online education.
• Economic Affairs Committee leads outpouring of AMP member engagement regarding CMS’ proposed National Coverage Determination for NGS for advanced cancer.
• T&E Committee launches popular Fellow In Service Exam (FISE) Question Bank, in collaboration with the MGP Program Directors Council.
• Professional Relations Committee continues to lead in advocacy regarding oversight of Laboratory Developed Testing Procedures (LDPs), educating hill staff on the negative impact on patient care of any FDA-centric approach.
• AMP leads advocacy on National Coverage Determination for Next Generation Sequencing for Advanced Cancer
President: Victoria M. Pratt, PhD, FACMG
Annual Meeting: Baltimore Convention Center, Baltimore, MD, November 7-9, 2019
• AMP celebrates its 25th anniversary and JMD’s 20th anniversary.
• Instead of giving anniversary “tchotchkes” to meeting attendees, AMP donates $5,000 to Health Care for the Homeless, a Baltimore nonprofit.
• Pilots “Short Course Day” with guest clinician society sessions by IDSA and ACMGG.
• Advocacy Day held on Captiol Hill.
• AMP welcomes eighth affiliate, Middle East Molecular Biology Sources (MEMBS).
• Second Global Congress held May 16-18 in Hong Kong.
• Number of users on AMPEDTM Online Education surges to over 4,000.
• AMP Board approves program expansion to significantly increase production of clinical practice guidelines.
• AMP holds inaugural Molecular Pathology Economics Summit.
President: Karen Weck, MD
Annual Meeting: Virtual Meeting and Networking Experience, November 16-20
• AMP hosts first its virtual meeting due to COVID-19 pandemic
• Due to the pivot to a virtual experience and dramatic, unforseen constraints on members' departmental budgets, AMP's Board of Directors approved the lowest member registration rates ever offered for an AMP meeting - including a $10 rate for Trainee members.
• AMP played a pivotal role in advocating for the laboratory community and the patients we serve since the outset of the novel coronavirus pandemic. Members worked closely with regulators and the media to educate stakeholders on nuances in the complex diagnostic landscape. In addition, AMP members ramped up COVID-19 testing while also continuing routine testing around the world, sharing resources and expertise to aid patients and their colleagues.
• AMP launched two surveys to collect real-time data from laboratories conducting COVID-19 testing, as well as a survey for laboratories conducting cancer testing during the pandemic.
• The Patient Engagement Subcommittee (part of the Professional Relations Committee) launched "Molecular Medicine for Patients," a microsite with educational resources about molecular testing geared to patients and patient advocates
• AMP moves all online education content to a new learning management system to enhance the users' experience while also debuting new resources such as flash cards, microlearning modules, and new "Molecular in My Pocket" cards from the Training & Education Committee
• AMP subcommittees expanded outreach to their members through new "Subdivision Spotlights," a monthly publication highlighting a different subdivision each time.
• Past and current members of the AMP Economic Affairs Committee published "Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage and Reimbursement"
• AMP Infectious Diseases leadership published "Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership"
• AMP and CAP publish joint guideline: "Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American Pathologists"
• Journal of Molecular Diagnostics moves to monthly publication schedule